Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Talat Haqqi is active.

Publication


Featured researches published by Talat Haqqi.


The FASEB Journal | 1998

Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation

Seiji Kondo; Yoshikazu Tanaka; Yasuko Kondo; Masahiro Hitomi; Gene H. Barnett; Yukihito Ishizaka; Jinbo Liu; Talat Haqqi; Akiko Nishiyama; Bryant Villeponteau; John K. Cowell; Barbara P. Barna

Telomerase, the enzyme that elongates telomeric DNA (TTAGGG)n, may be involved in cellular immortality and oncogenesis. To investigate the effect of inhibition of telomerase on tumor cells, we transfected the antisense vector against the human telomerase RNA into human malignant glioma cells exhibiting telomerase activity. After 30 doublings, some subpopulations of transfectants expressed a high level of interleukin‐1β‐converting enzyme (ICE) protein and underwent apoptosis. In contrast, other subpopulations also showed enhanced ICE protein but escaped from apoptotic crisis and continued to grow, although their DNA synthesis, invasive ability, and tumorigenicity in nude mice were significantly reduced. Surviving cells demonstrated increased expression of glial fibrillary acidic protein and decreased motility, consistent with a more differentiated state. These cells also contained enhanced expression of the cyclin‐dependent kinase inhibitors (CDKIs) p21 and p27. Treatment of surviving nonapoptotic cells with antisense oligonucleotides against p27, but not p21, induced apoptotic cell death, suggesting that p27 may have protected differentiating glioma cells from apoptosis. These data show that treatment with antisense telomerase inhibits telomerase activity and subsequently induces either apoptosis or differentiation. Regulation of these two distinct pathways may be dependent on the expression of ICE or CDKIs.—Kondo, S., Tanaka, Y., Kondo, Y., Hitomi, M., Barnett, G. H., Ishizaka, Y., Liu, J., Haqqi, T., Nishiyama, A., Villeponteau, B., Cowell, J. K., Barna, B. P., Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J. 12, 801–811 (1998)


Oncogene | 1998

Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis

Yasuko Kondo; Seiji Kondo; Yoshikazu Tanaka; Talat Haqqi; Barbara P. Barna; John K. Cowell

Malignant glioblastomas grow very rapidly and are generally resistant to either DNA-damaging drugs or γ-irradiation. If tumor cells could be made more susceptible to cell death with treatments, this would clearly represent a significant improvement in the success of treatment. Recently, telomerase has become a focus of interest among oncologists as a target for treating cancer cells. Telomerase elongates telomeric DNA repeats (TTAGGG)n and is important in protecting and replicating DNA. The vast majority of tumor cells, indeed, express telomerase activity whereas normal somatic cells, except for a few cells, do not. Since telomerase is essential for protecting DNA, we may be able to make tumors more sensitive to treatments with DNA-damaging drugs by inhibiting telomerase activity. In this study, we used cis-diamminedichloroplatinum (cisplatin)-sensitive U87-MG cells and cisplatin-resistant U251-MG of human malignant glioblastoma cell lines. U87-MG cells did not express telomerase activity, whereas telomerase was highly detected in U251-MG cells. Interestingly, inhibition of telomerase with an antisense telomerase expression vector not only decreased telomerase activity but also increased susceptibility to cisplatin-induced apoptotic cell death in U251-MG cells. These findings suggest that treatment with antisense telomerase may represent a new chemosensitisation for tumors resistant to anticancer drugs.


Human Gene Therapy | 1998

FADD gene therapy for malignant gliomas in vitro and in vivo

Seiji Kondo; Yukihito Ishizaka; Takashi Okada; Yasuko Kondo; Masahiro Hitomi; Yoshikazu Tanaka; Talat Haqqi; Gene H. Barnett; Barbara P. Barna


Experimental Cell Research | 1997

Involvement of p53 and WAF1/CIP1 in γ-Irradiation-Induced Apoptosis of Retinoblastoma Cells

Yasuko Kondo; Seiji Kondo; Jinbo Liu; Talat Haqqi; Gene H. Barnett; Barbara P. Barna


Ejc Supplements | 2008

Stat3 activation is required for the growth of U87 cell-derived tumours in mice

Atreyi Dasgupta; Baisakhi Raychaudhuri; Talat Haqqi; Richard A. Prayson; Erwin G. Van Meir; Michael A. Vogelbaum; Saikh Jaharul Haque


Journal of Neurosurgery | 1998

Antagonist effect of insulin-like growth factor I on protein kinase inhibitor-mediated apoptosis in human glioblastoma cells in association with bcl-2 and bcl-xL.

Steven A. Toms; Aleck Hercbergs; Jinbo Liu; Seiji Kondo; Talat Haqqi; Graham Casey; Koichi Iwasaki; Gene H. Barnett; Barbara P. Barna


Cancer Research | 1998

Retroviral Transfer of CPP32β Gene into Malignant Gliomas in Vitro and in Vivo

Seiji Kondo; Yoshikazu Tanaka; Yasuko Kondo; Yukihito Ishizaka; Masahiro Hitomi; Talat Haqqi; Jinbo Liu; Gene H. Barnett; Emad S. Alnemri; Barbara P. Barna


Journal of Immunology | 1997

The CDK inhibitor, p27Kip1, is required for IL-4 regulation of astrocyte proliferation.

Jinbo Liu; W M Flanagan; Judith Drazba; M L Estes; Gene H. Barnett; Talat Haqqi; Seiji Kondo; Barbara P. Barna


Autoimmunity | 1995

Determinant-regulated onset of experimental autoimmune encephalomyelitis: distinct epitopes of myelin proteolipid protein mediate either acute or delayed disease in SJL/J mice.

Vincent K. Tuohy; Dawn Thomas; Talat Haqqi; Min Yu; Justin M. Johnson


Investigative Ophthalmology & Visual Science | 1998

Involvement of interleukin-1beta-converting enzyme in apoptosis of irradiated retinoblastomas.

Yasuko Kondo; Jinbo Liu; Talat Haqqi; Barbara P. Barna; Seiji Kondo

Collaboration


Dive into the Talat Haqqi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yukihito Ishizaka

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

John K. Cowell

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Akiko Nishiyama

University of Connecticut

View shared research outputs
Researchain Logo
Decentralizing Knowledge